Relief Therapeutics Holding Stock Market Value
| RLFTF Stock | USD 5.36 0.22 3.94% |
| Symbol | Relief |
Relief Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Relief Therapeutics' otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Relief Therapeutics.
| 11/06/2023 |
| 11/30/2024 |
If you would invest 0.00 in Relief Therapeutics on November 6, 2023 and sell it all today you would earn a total of 0.00 from holding Relief Therapeutics Holding or generate 0.0% return on investment in Relief Therapeutics over 390 days. Relief Therapeutics is related to or competes with Analog Devices, Entegris, NioCorp Developments, Vindicator Silver, Valens, and Tower Semiconductor. Relief Therapeutics Holding AG, a biopharmaceutical company, provides patients with therapeutic relief from serious dise... More
Relief Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Relief Therapeutics' otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Relief Therapeutics Holding upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 8.52 | |||
| Information Ratio | 0.2215 | |||
| Maximum Drawdown | 69.59 | |||
| Value At Risk | (12.41) | |||
| Potential Upside | 24.75 |
Relief Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Relief Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Relief Therapeutics' standard deviation. In reality, there are many statistical measures that can use Relief Therapeutics historical prices to predict the future Relief Therapeutics' volatility.| Risk Adjusted Performance | 0.187 | |||
| Jensen Alpha | 3.13 | |||
| Total Risk Alpha | 0.8172 | |||
| Sortino Ratio | 0.3285 | |||
| Treynor Ratio | (1.84) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Relief Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Relief Therapeutics Backtested Returns
Relief Therapeutics is dangerous given 3 months investment horizon. Relief Therapeutics maintains Sharpe Ratio (i.e., Efficiency) of 0.2, which implies the firm had a 0.2% return per unit of risk over the last 3 months. We were able to interpolate and analyze data for twenty-eight different technical indicators, which can help you to evaluate if expected returns of 2.32% are justified by taking the suggested risk. Use Relief Therapeutics Semi Deviation of 6.62, coefficient of variation of 430.31, and Risk Adjusted Performance of 0.187 to evaluate company specific risk that cannot be diversified away. Relief Therapeutics holds a performance score of 15 on a scale of zero to a hundred. The company holds a Beta of -1.59, which implies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Relief Therapeutics are expected to decrease by larger amounts. On the other hand, during market turmoil, Relief Therapeutics is expected to outperform it. Use Relief Therapeutics downside variance, and the relationship between the treynor ratio and kurtosis , to analyze future returns on Relief Therapeutics.
Auto-correlation | -0.89 |
Excellent reverse predictability
Relief Therapeutics Holding has excellent reverse predictability. Overlapping area represents the amount of predictability between Relief Therapeutics time series from 6th of November 2023 to 19th of May 2024 and 19th of May 2024 to 30th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Relief Therapeutics price movement. The serial correlation of -0.89 indicates that approximately 89.0% of current Relief Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.89 | |
| Spearman Rank Test | -0.68 | |
| Residual Average | 0.0 | |
| Price Variance | 4.91 |
Relief Therapeutics lagged returns against current returns
Autocorrelation, which is Relief Therapeutics otc stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Relief Therapeutics' otc stock expected returns. We can calculate the autocorrelation of Relief Therapeutics returns to help us make a trade decision. For example, suppose you find that Relief Therapeutics has exhibited high autocorrelation historically, and you observe that the otc stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Relief Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Relief Therapeutics otc stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Relief Therapeutics otc stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Relief Therapeutics otc stock over time.
Current vs Lagged Prices |
| Timeline |
Relief Therapeutics Lagged Returns
When evaluating Relief Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Relief Therapeutics otc stock have on its future price. Relief Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Relief Therapeutics autocorrelation shows the relationship between Relief Therapeutics otc stock current value and its past values and can show if there is a momentum factor associated with investing in Relief Therapeutics Holding.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in Relief OTC Stock
Relief Therapeutics financial ratios help investors to determine whether Relief OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Relief with respect to the benefits of owning Relief Therapeutics security.